Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Dogecoin active addresses fall 78% – Will DOGE stay below $0.09?

Dogecoin active addresses fall 78% – Will DOGE stay below $0.09?

AMBCryptoAMBCrypto2026/02/28 11:03
By:AMBCrypto

Dogecoin [DOGE] extended its bearish streak as geopolitical tensions escalated following Israel’s attack on Iran. 

After rejecting resistance at $0.106, DOGE has faced strong downward pressure, closing at lower lows for three consecutive sessions. 

The weakness erased recent gains, driving the price down to $0.088. In addition, the memecoin slipped below its short‑term EMA20 at $0.098, underscoring the intensity of the downside momentum.

At press time, DOGE traded at $0.089, down 10.48%, extending its bearish structure. 

On-chain activity plummets 78% 

DOGE’s weakened structure has persisted because of reduced on-chain activity and falling adoption levels. In fact, some holders have sold and left the market entirely. Santiment data showed that on-chain activity has fallen significantly. 

Dogecoin active addresses fall 78% – Will DOGE stay below $0.09? image 0

Source: Santiment

At the time of writing, the memecoin’s Price DAA Divergence dropped to a two-month low of -46%. Such extremely low levels indicated reduced demand and network usage, with fewer users actively engaging with the network. 

As such, Dogecoin lacked adequate organic demand, a necessity for any gains. As a result, Daily Active Addresses have plunged 78.34% from 87.7k to 19k in February. 

Dogecoin active addresses fall 78% – Will DOGE stay below $0.09? image 1

Source: Santiment

The decline in active users suggests that most traders have either closed positions or are sitting on the sidelines. 

Sellers totally dominate the market

Amid rising geopolitical tensions and a massive sell-off in the crypto market, DOGE investors have also intensified their selling pressure.

On the Futures side, the memecoin recorded a major sell-off, recording $736 million in outflows compared to $659 million in inflows. As a result, Futures Netflow plunged 418% to -$77.39 million, a clear sign of aggressive selling.

Dogecoin active addresses fall 78% – Will DOGE stay below $0.09? image 2

Source: CoinGlass

With sellers dominating futures, it signaled reduced exposure, as they feared more losses. At the same time, with the drop below $0.09, the liquidation rate skyrocketed.

Dogecoin recorded $6.5 million in Long position liquidations, with $3.3 million in longs liquidated over the past four hours.

Dogecoin active addresses fall 78% – Will DOGE stay below $0.09? image 3

Source: CoinGlass

On the spot, the memecoin saw 976.75 million in Sell Volume compared to 928 million in Buy Volume. As a result, Dogecoin saw a negative Buy Delta of -48 million, a clear sign of aggressive spot selling.

Dogecoin active addresses fall 78% – Will DOGE stay below $0.09? image 4

Source: Coinalyze

Often, such sellers’ dominance across all market participants accelerates downward momentum, leading to lower prices.

What’s next for DOGE?

Dogecoin is currently under intense selling pressure amid the broader crypto market sell-off. At the same time, the memecoin’s fundamentals have weakened, creating space for a market freefall even with little trigger.

As a result, the negative index of Directional Movement Index (DMI) jumped to 54 as of writing, while the positive index fell to 28. These momentum indicators showed strong bearish momentum and a high likelihood of continuation.

Dogecoin active addresses fall 78% – Will DOGE stay below $0.09? image 5

Source: TradingView

Therefore, if the market sell-off persists, DOGE could drop towards $0.0800. For a trend reversal, the memecoin needs to close above its short-term moving averages, the 20- and 50-EMAs.

In doing so, the memecoin will be strong enough to reclaim and hold its critical $0.1 level.

Final Summary

  • DOGE dropped 10.48%, breaching $0.09 support, hitting a low of $0.088. 
  • Dogecoin’s downtrend continued amid intense selling pressure and weakened on-chain activity. 
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

AI Sell-off Hits Anthropic IPO, Potential Valuation Expected to Drop to $1.2–1.3 Trillion

The valuation range discussed by potential investors has been lowered from the previous high of $2 trillion to between $1.2 trillion and $1.3 trillion, and some strategists have even suggested going below $1 trillion to ensure safety. In the face of significant market volatility and financial concerns such as quarterly losses, Anthropic is facing tough decisions, including a discounted valuation, reducing the size of the offering, or postponing the listing.

华尔街见闻•2026/11/06 13:42
AI Sell-off Hits Anthropic IPO, Potential Valuation Expected to Drop to $1.2–1.3 Trillion

Moderna Q3 revenue up 29% year-on-year, far exceeding expectations, raises full-year revenue growth guidance to 15%-25% | Earnings Report Insight

Moderna's Q3 revenue increased by 29% year-on-year to $1.31 billion, with profits significantly exceeding expectations. The company raised its 2026 revenue growth guidance to 15%-25%. The ramp-up of next-generation COVID-19 and flu vaccines, along with international market expansion, has driven performance improvement. Phase III data for the personalized cancer vaccine has also shown positive progress. The company is simultaneously advancing cost reduction and pipeline R&D, with year-end cash expectations significantly raised.

华尔街见闻•2026/11/06 13:23

Eli Lilly (LLY.US) "lowers its stance" and joins forces with former rival Hims (HIMS.US) to compete for the self-pay weight loss drug market

Eli Lilly is collaborating with Hims & Hers Health, leveraging the telehealth company’s large customer base to expand access to its blockbuster weight loss drugs and boost sales of medications, including its new oral weight loss drug Foundayo.

智通财经•2026/11/06 12:37
Eli Lilly (LLY.US) "lowers its stance" and joins forces with former rival Hims (HIMS.US) to compete for the self-pay weight loss drug market